Ingredion Incorporated
Ingredion Incorporated Increases Quarterly Dividend to $0.82 per Share
Ingredion Incorporated Increases Quarterly Dividend to $0.82 per Share
WESTCHESTER, Ill., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.82 per share on the Company’s common stock. The dividend is payable on Oct. 21, 2025, to stockholders of record at the close of business on Oct. 1, 2025. This is the 11th consecutive year Ingredion’s board approved a quarterly dividend increase in the third quarter.
ABOUT THE COMPANY
Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2024 annual net sales of approximately $7.4 billion, the company turns grains, fruits, vegetables, and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion's Idea Labs® innovation centers around the world and more than 11,000 employees, the company co-creates with customers and fulfills its purpose of bringing the potential of people, nature, and technology together to make life better. Visit ingredion.com for more information and the latest company news.
CONTACT:
Investors: Noah Weiss, 773-896-5242
Media: Rick Wion, 708-209-6323
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
DeFi Technologies Inc.28.8.2025 05:17:30 CEST | Press release
UPDATE -- Valour Launches Eight New ETPs on Spotlight Stock Market, Including Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena (ENA), and Celestia (TIA)
Bitget Limited28.8.2025 04:16:00 CEST | Press release
Bitget COO Vugar Usi Zade Speaks on Future of Web3 at Economic Times World Leaders Forum
PARKEN Sport & Entertainment A/S27.8.2025 22:55:02 CEST | Press release
Forventninger til 2025
Countdown For A Cure27.8.2025 22:52:50 CEST | Press release
Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research
EarlyHealth Group27.8.2025 22:08:44 CEST | Press release
Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom